Sulfasalazine-Induced Interstitial Fibrosis

Kerget B., ARAZ Ö., Ucar E., Aydin O., AKGÜN M., SAĞLAM L.

EURASIAN JOURNAL OF MEDICINE, cilt.50, sa.3, ss.207-209, 2018 (ESCI) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50 Sayı: 3
  • Basım Tarihi: 2018
  • Doi Numarası: 10.5152/eurasianjmed.2018.17302
  • Dergi Adı: EURASIAN JOURNAL OF MEDICINE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.207-209
  • Atatürk Üniversitesi Adresli: Evet

Özet

Sulfasalazine has been used in the treatment of inflammatory bowel disease for over 60 years. Although the drug is frequently associated with gastrointestinal adverse effects, pulmonary adverse effects are very rare. Herein, we report a case of interstitial fibrosis resulting from 4-month sulfasalazine therapy for ulcerative colitis in a patient under long-term follow-up in our clinic due to chronic obstructive pulmonary disease.